The role of Ca 2+ in oocyte activation during In Vitro fertilization: Insights into potential therapies for rescuing failed fertilization by Swann, Karl
This is an Open Access document downloaded from ORCA, Cardiff University's institutional
repository: http://orca.cf.ac.uk/113882/
This is the author’s version of a work that was submitted to / accepted for publication.
Citation for final published version:
Swann, Karl 2018. The role of Ca 2+ in oocyte activation during In Vitro fertilization: Insights into
potential therapies for rescuing failed fertilization. BBA - Molecular Cell Research 1865 (11) , pp.
1830-1837. 10.1016/j.bbamcr.2018.05.003 file 
Publishers page: http://dx.doi.org/10.1016/j.bbamcr.2018.05.003
<http://dx.doi.org/10.1016/j.bbamcr.2018.05.003>
Please note: 
Changes made as a result of publishing processes such as copy-editing, formatting and page
numbers may not be reflected in this version. For the definitive version of this publication, please
refer to the published source. You are advised to consult the publisher’s version if you wish to cite
this paper.
This version is being made available in accordance with publisher policies. See 
http://orca.cf.ac.uk/policies.html for usage policies. Copyright and moral rights for publications
made available in ORCA are retained by the copyright holders.
1 
 
 
The role of Ca2+ in oocyte activation during In Vitro Fertilization: insights into 
potential therapies for rescuing failed fertilization.   
 
Karl Swann 
School of Biosciences,  
Cardiff University 
Sir Martin Evans Building, Museum Avenue 
Cardiff CF10 3AX.  
UK.  
Tel. +44 2920 879009.  
swannk1@cardiff.ac.uk 
 
Key words:   oocyte; fertilization, Ca2+ oscillations; sperm; phospholipase; ionophore.  
 
Abbreviations:  ICSI, intracytoplasmic sperm injection; PLC, phospholipase Czeta; 
CDK1, cyclin dependent kinase 1; MPF, maturation promoting factor.   
2 
 
Abstract 
At fertilization the mature mammalian oocyte is activated to begin development by a 
sperm-induced series of increases in the cytosolic free Ca2+ concentration. These so 
called Ca2+ oscillations, or repetitive Ca2+, are also seen after intracytoplasmic sperm 
injection (ICSI) and are primarily triggered by a sperm protein called phospholipase 
Czeta (PLC). Whilst ICSI is generally an effective way to fertilizing human oocytes, 
there are cases where oocyte activation fails to occur after sperm injection. Many 
such cases appear to be associated with a PLC deficiency. Some IVF clinics are 
now attempting to rescue such cases of failed fertilization by using artificial means of 
oocyte activation such as the application of Ca2+ ionophores. This review presents 
the scientific background for these therapies and also considers ways to improve 
artificial oocyte activation after failed fertilization.  
1. Introduction 
At fertilization in mammals, the sperm initiates a series of events that activates the 
development of the mature metaphase II-arrested oocyte into a zygote and early 
embryo. In metaphase II mammalian oocytes (often just called ‘eggs’) there are a 
distinctive series of transient rises in free cytosolic Ca2+ that persist for several hours 
after sperm oocyte interaction [1]. These rises are referred to as Ca2+ oscillations, or 
repetitive Ca2+ spikes (see Fig.1). The Ca2+ oscillations activate the oocyte and hold 
the key to understanding how the sperm starts embryo development. We know a 
considerable amount about how the sperm generates the Ca2+ transients and the 
role of Ca2+ in oocyte activation [1-3]. This knowledge has the potential to have a 
direct clinical benefit, but this has yet to be fully realised. In this review I outline our 
knowledge of Ca2+ in oocyte activation at fertilization in mammals, with a particular 
note to studies on human oocytes. I will then consider the scientific basis for the use 
of treatments that attempt to promote oocyte activation as part of human IVF 
treatment.   
In mammals the ovulated oocyte is arrested before fertilization at the second 
metaphase of meiosis (MII). The activation of the oocyte at fertilization involves the 
resumption of meiosis as indicated by a metaphase to anaphase transition, and the 
emission of a second polar body [3]. This occurs about an hour after sperm oocyte 
fusion in the mouse. The formation of two pronuclei (one from the sperm and one 
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from the retained set of maternal chromosomes) represents the completion of 
meiosis and entry into the first interphase of the zygotic cell cycle [2,3]. This occurs 
several hours after second polar body emission. As well as meiotic resumption, 
mammalian oocyte activation involves the exocytosis of cortical granules which lead 
to modification of the zona pellucida to prevent sperm penetration [2]. Both of these 
key events are physiologically triggered by increases in cytosolic Ca2+ which 
stimulate calmodulin-dependent kinases, or myosin light chain kinases [1-3]. The 
step initiating meiotic resumption is the Ca2+-dependent inactivation of cyclin B and 
its cyclin dependent kinase (CDK1) activity in the oocyte, which then leads to a 
release from meiotic metaphase arrest [3]. If CDK1 activity is kept low, the oocyte 
will complete meiosis and enter interphase as indicated by the formation of 
pronuclei.   For the purposes of this review, oocyte activation will imply the 
completion of meiosis, hence second polar body emission and pronuclear formation. 
If pronuclear formation is not the end point of ‘oocyte activation’ it will be specifically 
stated.  
2. The pattern of Ca2+ increases in mammalian oocytes during fertilization.   
Studies in the 1970s first showed that a single transient cytosolic Ca2+ increase 
occurred during activation at fertilization in sea urchin and fish eggs and oocytes.   
Studies on mammalian oocytes were not far behind. A series of oscillatory increases 
in cytosolic free Ca2+ were first demonstrated in mouse oocytes during fertilization 
using the photoprotein aequorin [4]. In hamster oocytes it was also shown that 
fertilization induces a series of Ca2+ oscillations that can be readily monitored by 
Ca2+ activated membrane potential hyperpolarizations which occur in synchrony with 
Ca2+ increases [1,5]. Thanks to use of Ca2+-sensitive fluorescent dyes, we now know 
that Ca2+ oscillations also occur at fertilization in cow, pig, and rat oocytes [1,2,6]. In 
addition, it has been shown that cytosolic Ca2+ oscillations also occur in human 
oocytes during in vitro fertilization, IVF [7]. The Ca2+ oscillations in fertilizing 
mammalian oocytes are distinctive in being of low frequency with one Ca2+ ‘spike’ 
occurring about every 10 minutes, as in the mouse oocytes, or about one spike once 
every 30 to 60 mins, as in human, pig or cow oocytes. The initial Ca2+ increase at 
fertilization in the mouse is seen a few minutes after sperm-oocyte fusion and travels 
as a wave crossing the oocyte in about 10 seconds [1,8]. However, the subsequent 
Ca2+ spikes occur as very rapid waves of Ca2+ release that cross the oocyte in about 
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1 second [8].  Hence, Ca2+ oscillations in mammalian oocytes are distinctive in that 
they have very prolonged intervals between spikes, and yet each Ca2+ increase is 
initiated by a fast wave of >50 m/sec.  
The mechanism of Ca2+ oscillations in mammalian oocytes involves the production of 
inositol (1,4,5) trisphosphate production (InsP3). This leads to the stimulation of Ca2+ 
release via InsP3 receptors (IP3Rs). The primary stimulus for InsP3 appears to be the 
sperm specific phospholipase Czeta (PLC) which can enter the oocyte after gamete 
fusion [1,2,6]. Microinjecting PLC RNA into oocytes causes Ca2+ oscillations very 
similar to fertilization in mouse and humans [9,10]. The existence of PLC inside the 
sperm head can also explain the success of intracytoplasmic sperm injection (ICSI) 
in mice [11]. With ICSI, a whole sperm is first ‘damaged’ slightly with the injection 
pipette and then injected into the oocyte which then activates and can develop to 
term. ICSI also causes Ca2+ oscillations similar to those seen at fertilization in both 
mouse and human oocytes and the ‘damaging’ of the sperm promotes the 
occurrence of oscillations presumably by facilitating the release of PLC [12-14].  
There is substantial evidence that PLC is physiologically significant in causing the 
Ca2+ oscillations at fertilization. In mouse it has been shown to be present in sperm 
in the post-acrosomal region, which is the first part of the sperm to contact the 
oocyte cytosol [1,2,6]. PLC is also present in an amount that is able to cause a 
normal pattern of Ca2+ oscillations at fertilization [9]. Recently the phenotype of PLC 
knock-out mice was reported by two independent groups. In both studies it was 
found that sperm lacking a functional PLC protein were unable to cause Ca2+ 
oscillations after ICSI [15,16 ].  Hence PLC for ICSI is synonymous with so-called 
SOAF (sperm-borne oocyte activating factor) that was characterized using ICSI [11]. 
However, both studies using different types of PLC knock out mice, also found that 
males can still produce offspring, albeit of much reduced litter size [15,16]. In 
addition, it was found that in IVF sperm lacking PLC can still give rise to about 70% 
oocyte activation with very much delayed pronuclear formation and a high degree of 
polyspermy. Interestingly, a limited number of Ca2+ oscillations, which were delayed 
by an hour after gamete fusion, can be seen in oocytes fertilized by PLC KO sperm 
[16]. This suggests that the sperm may have an alternative factor that can cause 
Ca2+ release in oocytes. For reasons that are unclear this factor is not active in ICSI, 
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but is active when freshly prepared sperm fertilize oocytes in IVF. The nature of the 
alternative factor remains to be determined. It does not appear to be as potent as 
PLC in causing Ca2+ release. Since its effects are delayed it is still true to say that 
PLC is the primary stimulus for oocyte activation. Nevertheless, this secondary 
factor may represent a novel agent for triggering Ca2+ release in oocytes. Its 
existence in humans remains unknown. 
It is worth noting that PLC is the only sperm specific protein that has been 
reproducibly shown to cause Ca2+ oscillations in mammalian oocytes. It was reported 
in 2015 that a protein called PAWP (post acrosomal WW-domain binding protein) 
was able to cause Ca2+ oscillations in mouse and human oocytes [17]. The authors 
of this study suggest that PAWP might be sperm factor active in IVF and ICSI [17]. 
However, the key findings in this paper are not reproducible [18]. Sperm from PAWP 
knock-out male mice also cause completely normal Ca2+ oscillations after ICSI and 
in vitro fertilization, so a role of PAWP in oocyte activation seems highly unlikely [19]. 
It is clearly not the secondary sperm factor.   
3. The importance of Ca2+ oscillations in activation of mammalian oocytes.  
It was first shown in the 1970s that oocytes from hamsters can be stimulated to 
activate by applying the Ca2+ ionophore A23187 [20]. These initial studies showed 
that A23187 works in a variety of eggs and oocytes by releasing Ca2+ from 
intracellular stores [20,21]. Subsequently it was shown that direct injection of Ca2+ 
ions also activates mouse oocytes, and in this case the parthenogenetic embryos 
were shown to develop to the blastocyst stage [22]. It was later shown that Ca2+ 
ionophore A23187 can also activate human oocytes [23]. Hence Ca2+ influx by 
injection, or Ca2+ release by A23187 act as parthenogenetic stimuli. However, 
studies on human oocytes were inconsistent because other groups found that the 
Ca2+ ionophore, ionomycin, which acts like A23187 and causes a single large Ca2+ 
rise, did not lead to oocyte activation [24]. Another report also found that A23187 
was ineffective in activating human oocytes [25]. Instead it was found that the protein 
synthesis inhibitor puromycin could activate human oocytes [25]. So, from the 
earliest studies the effectiveness of ionophore in human oocyte activation appeared 
variable.   
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The conflicting data on human oocytes is not surprising since many studies have 
found that Ca2+ ionophores are not very effective when used on their own as a 
parthenogenetic stimulus in mammals. To activate oocytes, ionophores are 
combined with a protein synthesis inhibitor, or a protein kinase inhibitor such as 6-
dimethyl aminopurine [26]. Such double treatments is standard practice for 
parthenogenetic oocyte activation in domestic animals and is commonly used as an 
oocyte activation method after nuclear transfer. The reason there is a need for two 
stimuli appears to be the dynamic nature of cyclin B synthesis. The activity of CDK1 
holds the oocyte in meiotic arrest and CDK1 activity depends on continuous cyclin B 
synthesis [3]. A single Ca2+ increase leads to proteolysis of cyclin B and a reduction 
in the CDK1 activity that promotes meiotic resumption [27]. However, if there is only 
a single Ca2+ rise cyclin B is resynthesized and CDK1 activity returns, leading to 
oocyte re-arrest. The return of CDK1 activity is prevented by inhibiting protein 
kinases, or protein synthesis, which explains why activation is most effective with 
ionophore plus a protein kinase or protein synthesis inhibitor [3,27].  It’s worth noting 
here that the very first study on the effect of ionophores in hamster oocytes found 
that A23187 was more effective in activating oocytes with a longer incubation in Ca2+ 
free media [20]. This is probably because long incubations in Ca2+ free media leads 
to inhibition of protein synthesis and hence this protocol effectively provides a double 
stimulus [28].  
An issue that became clear in these early studies is that most parthenogenetic 
activation agents do not mimic the response at fertilization. For example, ethanol 
(7% in culture media) that was once commonly used to activate mouse oocytes 
causes just one very large increase in Ca2+ in the oocyte [29]. As noted above, Ca2+ 
ionophores also only cause a single Ca2+ increase [29]. Exposing oocytes to high 
intensity electric fields (electroporation) in the presence of Ca2+ can also lead to a 
large rise in Ca2+, due to Ca2+ influx across the plasma membrane. However, again 
this only causes a single large Ca2+ increase [29,30]  (see Fig.2). Hence causing 
artificial Ca2+ influx, or artificial Ca2+ release, in mammalian oocytes does not 
generally trigger the Ca2+ oscillations as seen at fertilization [29].  
The first parthenogenetic stimulus shown to cause Ca2+ oscillations in mouse 
oocytes is incubation in medium where Sr2+ replaces the Ca2+ [31]. Ca2+ oscillations 
occur for as long as Sr2+ is present, which is typically for 2 hours in order to activate 
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mouse oocytes [31]. Significantly, Sr2+ media alone is an effective activator of mouse 
oocytes, even with ‘freshly ovulated’ oocytes that usually show a poor response to 
parthenogenetic stimuli [28]. Sr2+ is also effective in stimulating development to the 
blastocyst stage after failed fertilization with ICSI. For example, if sperm are heat 
treated, or taken from a mutant mice, and used in ICSI, the activation and 
development rates are very low [32,33]. These oocytes that have failed to fertilize 
after ICSI can be ‘rescued’ by treatment with Ca2+ ionophore, but a ‘rescue’ with Sr2+ 
medium is better at inducing activation and development to blastocyst. These data 
imply that the Ca2+ oscillations induced by Sr2+ are a more effective way of 
stimulating early development than the single large Ca2+ increase induced by 
ionophore. Unfortunately, these studies with Sr2+ have been restricted to mice 
because Sr2+ only appears to cause Ca2+ oscillations in rodent oocytes (see later).  
Whilst a single electroporation pulse causes a singular large Ca2+ rise in mammalian 
oocytes, multiple electroporation pulses can be used to cause more than one Ca2+ 
transient [30]. In order to do this the oocytes are placed between two electrodes in a 
medium of low ionic strength, such as 300mM glucose, to which is added a small 
amount (50M) of CaCl2 [30]. A brief voltage pulse is then applied across the 
electrodes. It is worth noting that if this is done in a standard electroporation device 
with a static chamber, multiple electroporation pulse leads to oocyte lysis. However, 
if oocytes are instead placed in a rapid perfusion microfluidic device, and then after 
each electroporation the oocyte is rapidly perfused (~200ms) with culture media, 
oocyte integrity is preserved. If the procedure of electroporation and rapid perfusion 
is repeated then a series of Ca2+ rises of predefined amplitude and duration can be 
induced [30]. With regards to understanding the Ca2+ oscillations, this type of 
electrical stimulation method has been used to show that multiple Ca2+ rises are 
required to bring down both the CDK1 and MAP kinase activity for long enough to 
allow the zygote to enter interphase and form pronuclei [34]. It has also been shown 
that the pattern of electroporation-induced Ca2+ increases also influences the timing 
of activation events such as pronuclear formation in mice [30].  
This rapid perfusion electroporation device has also been used on fertilized animal 
oocytes (i.e. zygotes). In rabbit zygotes it was also found that providing extra Ca2+ 
pulses increased implantation rates [35]. In mice it was further shown that varying 
the number of Ca2+ spikes from 2 or 3 spikes (spontaneous) to over 20 Ca2+ spikes 
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(imposed by electroporation), leads to different rates of implantation compared to 
control embryos [35]. The main conclusion from these variations is that either too few 
or too many Ca2+ spikes, compared to IVF, resulted in fewer pregnancies [36]. These 
data clearly suggest that Ca2+ oscillations can affect later development of embryos 
as well as oocyte activation. It also implies that there is an optimum stimulus range 
for later development and implantation.   
Microinjecting PLC RNA or PLC recombinant protein can also cause robust Ca2+ 
oscillations in mouse, pig, cow and human oocytes [1,6, 9,10,37-39]. It leads to high 
rates of oocyte activation and development to blastocysts. When it is used toa 
‘rescue’ oocyte activation after ICSI with heat-treated sperm, it is as effective as Sr2+ 
in triggering development to blastocyst stages [32]. This reinforces the idea that it is 
the Ca2+ oscillations that are key to developmental success. With PLC injection into 
mouse or cow oocytes it has also been found that, whilst low frequency Ca2+ spikes 
supported development to the blastocyst stage, injecting higher amounts of PLC 
RNA causes a high frequency of Ca2+ oscillations that are associated with embryo 
arrest during cleavage stages [38,40]. It clearly suggests that high frequency Ca2+ 
oscillations inhibit pre-implantation embryo development.  
Taken together these various studies have shown that stimulating oocytes with a 
very large Ca2+ increase can be effective in activating mammalian oocytes. However, 
the more general finding is that a single large Ca2+ increase that lasts typically less 
than 10 minutes only activates a fraction of a cohort of mammalian oocytes. 
Parthenogenetic stimuli such as Ca2+ ionophores are also found to be more effective 
when used on oocytes that are aged in vitro after ovulation, probably because cyclin 
B levels decline with age in vitro [3,28,29]. The most consistent way to activate 
oocytes and obtain good later development is to induce multiple, low frequency Ca2+ 
oscillations that, perhaps not surprisingly, mimic the Ca2+ response seen at 
fertilization. In human oocytes it is likely that about 10 to 20 Ca2+ transients at 
intervals in the range 30-60 minutes is the type of physiological pattern associated 
with successful development [7,14].   
4. Human IVF and failed oocyte activation.  
In human IVF or ICSI, oocytes or zygotes are examined about 16 to 18 hours later 
for signs of pronuclear formation. The lack of pronuclei is a sign of failed fertilization 
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and still occurs to some extent in all IVF clinics [41]. ICSI is now widely used as a 
means to overcome many cases of fertilization failure after conventional IVF, since 
the sperm is directly placed in the oocyte cytoplasm [42]. ICSI is used in a wide 
variety of cases such as those where there is a low sperm count, or where oocytes 
are cryopreserved. I shall concentrate on failed fertilization after ICSI since it is clear 
that the sperm is within the oocyte, and that any lack of fertilization is due to factors 
associated with the sperm processing or oocyte activation. The major cause of failed 
fertilization after ICSI appears to be failed oocyte activation [41-44]. There are two 
classes of failed fertilization in ICSI that may both be related to a lack of a Ca2+ 
signal. One is widely recognized, the other more insidious.  
The widely recognized fertilization failure after ICSI is referred to as total fertilization 
failure which means that all the oocytes collected in a treatment cycle fail to form 
pronuclei after injection of sperm. It is reported to occur in 1-4% of ICSI treatment 
cycles and these cases are generally associated with failed, or abortive oocyte 
activation [41-44]. There are numerous reports showing that failed fertilization after 
ICSI is associated with either a relative lack of PLC in the sperm, or otherwise with 
mutations in PLC that affects its activity in oocytes [45,46]. In some cases the 
human sperm has been shown to be deficient in its ability to cause Ca2+ oscillations 
after ICSI in mouse oocytes, which can be used as an effective bioassay of the 
sperm Ca2+ releasing ability [43,45]. There are also a number of cases reported 
where a mutation in PLC has been identified in men with repeated failed ICSI. In 
these cases the PLC mutation has been shown to inhibit PLC’s enzyme activity 
[46]. In one particularly notable case, two brothers were shown to have a 
homozygous mutation in the C2 domain of PLC [47]. This mutation disrupts PLC 
activity and reduces its expression in sperm. Whole genome sequencing showed 
that this was the only mutation of a known gene predicted to be disruptive of a 
protein’s structure. This suggests that a mutation in PLC alone in humans can 
cause male factor infertility. Other pronounced cases where PLC is lacking is in 
globozoospermia where the sperm lacks an acrosome and many other structures 
around the sperm head [43,46]. Many cases of globozoospermia are associated with 
a mutation in the Dpy1912 gene. In a mouse model where the Dpy1912 gene is 
deleted, the sperm are shown to lack PLC in the sperm head, and sperm from 
males fail to activate oocytes [48]. Again this suggests that a lack of PLC can play a 
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causal role in fertilization failure after ICSI. PLC deficiency in human sperm could 
account for many cases of total fertilization failure in human ICSI.  
The second and more insidious type of failed fertilization occurs during routine 
clinical ICSI. With ICSI the typical fertilization rates for a group of oocytes are around 
70% [41]. This is true even with morphologically normal sperm and oocytes [49]. 
Hence on average about 30% of human oocytes do not fertilize after ICSI. This 
represents a recurrent failure rate per oocyte, which is distinct from the total 
fertilization failure issue [41]. This may not be critical for generating embryos if there 
are 10 or more oocytes collected in a cycle, but it becomes significant if fewer 
oocytes are ovulated. It is also obvious that IVF clinics would prefer it if more oocytes 
would fertilize after ICSI since this would give more embryos to select for embryo 
transfer.   
There are indications that one of the problems with this recurrent fertilization failure 
is a lack of an adequate activation stimulus. For example, human sperm have been 
assessed for their ability to cause Ca2+ oscillations in oocytes after ICSI [14,50]. In 
cases of male factor infertility with total fertilization failure, the sperm generally fail to 
cause any Ca2+ oscillations. What is intriguing is that even sperm from control ‘fertile’ 
males are still variable. In a recent study, about 70% of control sperm were shown to 
cause more than 3 Ca2+ spikes in human oocytes [14]. With about 20% of sperm 
there were only 1 or 2 spikes, which is unlikely to activate oocytes, and 10% of 
control sperm did not cause any Ca2+ spikes at all. Hence, 30% of control sperm are 
not very effective at stimulating effective Ca2+ signals in human oocytes. Even with 
the sperm that did cause multiple Ca2+ spikes only 50% (overall) could be induced 
more than 10 Ca2+ spikes [14]. Hence, overall these data show that the PLC activity 
levels, or at least the ability of normal human sperm to cause Ca2+ signals are likely 
to be highly variable. This is consistent with antibody staining of human sperm which 
showed variable localization and often the absence of PLC, even in sperm from 
fertile males [51]. These data suggest that variable PLC activity from fertile sperm 
samples could well account for the recurrent ICSI failure.  
5. The use of Ca2+ ionophores in human oocyte activation.  
The above discussion suggests that a deficient activation stimulus, most notably a 
lack of PLC activity and a lack of Ca2+ signal, could underlie many cases of failed 
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fertilization after ICSI. As a result some clinics have tried to rescue cases of failed 
fertilization after ICSI by providing a separate stimulus in the form of Ca2+ ionophores 
such as A23187 or ionomycin. This can involve using ionophores on oocytes just 
after they have failed to activate (~16 hours), or else using ionophores for all oocytes 
in the subsequent treatment cycle.  There are now a number of reports showing that 
an incubation of ‘failed to fertilize’ oocytes in Ca2+ ionophores for ~ 10 mins can 
improve activation rates with ICSI [52-55]. A recent meta-analysis on the use of Ca2+ 
ionphore in ICSI concluded that ionophore treatment could significantly improve 
clinical pregnancy rates as well as oocyte activation [52-55]. Many such studies with 
Ca2+ ionophore have been retrospective studies where all oocytes in a treatment 
cycle were treated with ionophore.  This is usually because the fertilization rate was 
extremely low in the previous cycle.  Nevertheless, whilst improvements in activation 
and development rates are promising, in many cases the only ‘control oocytes’ have 
been those that failed to fertilize in the previous cycle. One randomized control trial 
where sibling oocytes were used as controls found that the use of a protocol 
involving  Ca2+ injection and then double ionomycin treatment was effective in 
improving fertilization and pregnancy rates in patients where there was evidence for 
a lack of Ca2+ releasing activity in the sperm [57]. Another study, again using sibling 
oocytes as controls for A23187 activation after sperm selection for ICSI found no 
obvious improvement in fertilization rates [58]. So, it is possible that only certain 
patients will benefit from oocyte activation with ionophore, or that benefits are more 
likely seen when more than one Ca2+ increase is induced [57].  In addition the 
composition of the medium affects the size of the Ca2+ response and its ability to 
activate oocytes so comparisons between clinics need to take into account any 
differences in protocols and preparations used [59]. It is also notable that clinics 
sometimes consider using multiple treatments with Ca2+ ionophore [57]. One 
assumes that this begins to mimic in some way the multiple Ca2+ increases at 
fertilization. However, one problem that arises is that the ionophore-induced Ca2+ 
increases are smaller with each application, and prolonged incubation in ionophores 
will probably destroy an oocyte [20].  
Since they can be toxic with prolonged exposure [20], concerns exist about the use 
of Ca2+ ionophores in clinical IVF. However, when Ca2+ ionophores are applied to 
mouse zygotes after fertilization, with a brief exposure designed to mimic the effect 
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of the extra Ca2+ rise, then development to blastocysts stage, and to term was 
normal [60].  Ca2+ ionophores have also been applied after ICSI with wobbler mouse 
sperm and development to term appeared to be normal [33]. Consequently, there 
are no direct indications that the extra Ca2+ rise caused by ionophore has an overt 
detrimental effect upon mouse development. Early indications are that ionophore 
activation in human oocytes also does not have obvious effect on the health of 
babies [61,62].  This should not be a surprise since during the ICSI procedure there 
is a large and long lasting Ca2+ increase [12], and oocyte cryopreservation is almost 
certainly associated with a significant Ca2+ increase [63]. If a single extra Ca2+ rise 
had a dramatic detrimental effect on embryo development then it is hard to see how 
ICSI or oocyte cryopreservation could be successful as clinical procedures. 
Nevertheless, the question remains as to whether ionophore treatment as some 
more subtle effect on embryos, or upon the long-term health of offspring. This will 
require longer-term studies with larger numbers of patients.  
As noted above, when Ca2+ ionophores are applied on their own they have limited 
capacity to activate mammalian oocytes, but when used in combination with ICSI the 
situation may be a little different. In failed ICSI, a sperm has been injected and this 
might introduce a small amount of PLC, which could sensitize the oocyte to Ca2+ 
elevating agents such as ionophores.  It has been found that applying ionophore 
after ICSI leads to a large Ca2+ increase followed by smaller Ca2+ oscillations [64]. It 
is not clear how common this type of response may be, nor whether these smaller 
oscillations are effective in promoting oocyte activation.   
 
6. Electrical activation of human oocytes.  
Another way to achieve human oocyte activation is to use an electroporation pulse in 
the presence of Ca2+. This type of electrical activation can rescue oocyte activation 
failure after ICSI. In one study that used sibling oocytes as a control group it was 
found that there was a small increase in the fertilization rate after ICSI [65]. It has 
also been shown that electrical activation can stimulate human oocyte activation and 
live births after injection of round spermatids [66]. In this latter study it was shown 
that the electrical pulse triggers a series of Ca2+ spikes after spermatid injection. The 
electrical pulse only causes a single Ca2+ increase in control oocytes, so it is likely 
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that a small amount of PLC introduced by the round spermatid may be sensitizing 
the oocyte to the electroporation induced Ca2+ influx [30]. Human round spermatids 
probably possess a small amount of PLC because they can cause Ca2+ oscillations 
when injected into mouse oocytes [67]. 
The protocols so far generally involve using a single electrical pulse, or else a series 
of pulses within a short time (< seconds), and hence there is still only one large Ca2+ 
increase [30]. There have been no studies carried out on human oocytes exposed to 
multiple, low frequency stimulation in a microfluidic device of the type used for 
mouse and rabbit oocytes by Ozil and colleagues. This is essentially for technical 
reasons since the microfluidic electroporation device is complex and requires 
specialist knowledge to build. It is not commercially available for clinical trials.   
 
7. Potential alternatives for activating human oocytes.  
Whilst most clinical treatment for failed fertilization has involved the use of 
ionophores there are some other possible treatments that have been, or might be 
tested. One agent that is obvious to consider is PLC. Injection of PLC RNA has 
been shown to stimulate Ca2+ oscillations in human oocytes, that failed to fertilize in 
IVF or ICSI, and these oocytes can develop to form blastocysts [10,68]. PLC RNA 
injection has also been shown to be more effective in stimulating development to the 
blastocyst stage than ionophore treatment or electrical activation [68]. However, the 
use of RNA injection is problematic. The main technical problem is that there is 
variable expression of PLC protein from the injected RNA. This means that the 
amount of PLC protein can vary considerably from one oocyte to another and 
excess PLC expression in the oocyte leads to cleavage stage arrest in mice, cow 
and human embryos [10,30,40]. The second issue with RNA is that it is genetic 
material and is many parts of the world it would not be permissible to inject it into an 
oocyte as a therapy for clinic treatment. A better prospect for PLC is to use the 
recombinant protein. PLC recombinant protein can be made in bacteria as a fusion 
tagged protein and can cause prolonged Ca2+ oscillations when injected into mouse 
or human oocytes [32,69,70]. It could potentially be injected at the same time as the 
sperm during ICSI and offer a simple way of activating the oocyte without the need 
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for further specific protocols. However, there are still issues to resolve before such 
recombinant PLC can be used in clinical IVF. PLC protein readily loses enzyme 
activity and its activity will need to be stabilized and calibrated before regular use. It 
is currently not available commercially for use in clinical trials by IVF clinics.  
Another activation stimulus mentioned above is incubation in media containing Sr2+ 
which reliably causes Ca2+ oscillations in mouse oocytes. There are some studies 
showing human oocyte activation, subsequent pregnancies and live births after ICSI 
followed by incubation in Sr2+ medium [71-73]. The protocols used involved 
incubating human oocytes for 10 min or 60 mins in 10mM Sr2+ [71-73], which is 
shorter than the standard treatment of 2 hours used for mouse oocytes.  The studies 
of Sr2+ in human oocytes are compilations of case reports where all oocytes within a 
collection cycle were treated, with no use of sibling control oocytes. Consequently, 
whilst pregnancies and live births have been achieved after ICSI and incubation of 
human oocytes in Sr2+, it is not known whether the Sr2+ treatment was inducing 
oocyte activation.  
In my lab, Sr2+ media has been tested on human oocytes many times  with no 
detection of Ca2+ oscillations, using the same 10mM Sr2+ (Ca2+ free) media used 
regularly to cause Ca2+ oscillations in mouse oocytes. The only time Ca2+ oscillations  
have been seen is with some oocytes after >10 hours of incubation in 20mM Sr2+, 
which leads to oocyte degeneration (Elgmati and Swann, unpublished data). Other 
labs, who regularly use Sr2+ to activate mouse oocytes, have also reported a similar 
lack of Ca2+ responses, or activation in human oocytes exposed to Sr2+ [74,75]. It is 
worth noting that despite Sr2+ being in widespread use in mouse oocytes for over 20 
years there are still no published papers showing Sr2+ media causing Ca2+ 
oscillations in human, pig or cow oocytes. The reasons why Sr2+ does not appear to 
cause Ca2+ release in non-rodent oocytes is unclear. It could be that Sr2+ does not 
cross the plasma membrane as effectively in some oocytes. Sr2+ influx in mouse 
oocytes is mediated via plasma membrane TRPV3 channels which can be 
stimulated to open by chemicals such as 2-APB and carvacrol [76]. However, 
TRPV3 channels also exist in human oocytes and in the presence of Sr2+ there are 
still no Ca2+ oscillations with incubations of 6 hours [75]. It seems unwarranted to 
offer a Sr2+ media ‘activation’ to patients as a therapy for failed fertilization until it has 
been shown that it can cause Ca2+ oscillations in human oocytes.  
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Apart from Sr2+ there are only a small number of chemicals that can cause Ca2+ 
oscillations in mature mouse oocytes. One such chemical is InsP3 itself, which of 
course has to be microinjected. However, this only leads to a short lasting series of 
Ca2+ oscillations in mouse oocytes, and whilst it can trigger some exocytosis , InsP3 
injection is unable to cause full activation (pronuclear formation) in mouse oocytes 
[42]. Injection of the IP3R agonist adenophostin causes a longer lasting series of 
Ca2+ oscillations and it has been used to activate mouse oocytes after spermatid 
injection [77]. However, we have found that adenophostin only causes high 
frequency, low amplitude Ca2+ oscillations in human oocytes (Sanders and Swann, 
unpublished data).   
Another effective trigger for large amplitude Ca2+ oscillations in both mouse, pig and 
human oocytes is thimerosal [6,78]. However, thimerosal is a sulfhydryl reagent 
which causes damage to the MII spindle [79]. One protocol that has proved effective 
in pig oocytes is to apply thimerosal and then reverse its effects by adding 
dithiothreitol to reduce the sulfhydryl groups on proteins. This protocol allows 
thimerosal to cause a large Ca2+ increase and activate pig oocytes [79]. However, 
the dithiothreitol has to be added 10mins after thimerosal which means that there is 
probably only time for a single Ca2+ increase before its actions are terminated. 
Consequently, thimerosal is not usable in a way that triggers low frequency Ca2+ 
oscillations.  
Although Ca2+ oscillations are clearly the physiological trigger for oocyte activation, it 
has been known for many years that some chemicals can activate oocytes without 
causing a Ca2+ increase. The latest such chemical to be shown to do this is TPEN 
which is a Zn2+ chelator that strips Zn2+ from the cell cycle-arresting protein EMI2, 
thus leading to meiotic resumption [80-81]. TPEN is effective in activating 
development in mouse oocytes and can support development after ICSI with 
inactivated sperm heads [80]. One study has suggested that it is able to activate 
human oocytes, but this was just from meiotic metaphase to anaphase, rather than 
pronuclear formation [82].  In pig oocytes TPEN was found to be effective in causing 
activation, but it was more effective when used at lower concentrations in 
combination with Ca2+ ionophore, which is similar to that of agents such as 
puromycin [81]. Again artificial stimuli often appear to be more effective when used in 
combinations.  
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8. Future Prospects.   
The role of Ca2+ in animal oocyte or egg activation first came to light in the 1970s. 
We now know that there is a role for InsP3 and PLC in triggering Ca2+ oscillations. 
Data on mouse and other animal oocytes also suggests that Ca2+ oscillations are 
probably a more effective way of activating development than a single large Ca2+ rise 
We also know that failed oocyte activation is a common cause of failed fertilization 
after ICSI. Currently, the only agent available for clinical use for activating oocytes is 
the Ca2+ ionophore A23187. The data thus far suggests that Ca2+ ionophores may be 
effective in improving activation rates for failed fertilization after ICSI, and that it may 
exert beneficial effects upon later development. Nevertheless, Ca2+ ionophores 
alone have not previously been found to be the optimal way of causing 
parthenogenetic oocyte activation in mammals. They could perhaps be regarded as 
a first generation treatment. It is likely that an improvement in human oocyte 
activation is possible if a stimulus can be provided that causes low frequency, large 
amplitude Ca2+ oscillations similar to those seen at fertilization. The only candidate 
methods that might do this so far, in human oocytes, are recombinant PLC and 
multiple electroporation.   
Another potential innovation for oocyte activation is monitor the occurrence of Ca2+ 
oscillations in human zygotes after ICSI.  It has been shown that there are brief and 
subtle movements, or spasms, in the cytoplasm of mouse and human zygotes during 
sperm, or PLC induced Ca2+ transients [83-85]. These spasms occur immediately 
following each Ca2+ transient and provide a relatively non- invasive way of 
monitoring how many Ca2+ spikes have occurred during fertilization. The pattern of 
such spasms has been linked to developmental potential in mice [83,85]. This type of 
technology could be developed to allow clinicians to assess whether any extra Ca2+ 
stimuli are required after poor fertilization in a treatment cycle. It could also be a new 
way to assess the effectiveness of any oscillatory stimulus in promoting further Ca2+ 
transients in the oocyte.   
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Figure Legends.  
Fig.1. Ca2+ oscillations during fertilization in a mouse oocyte. A typical pattern of 
oscillations is shown (10-20 Ca2+) spikes from a single oocyte.  The oocyte was 
microinjected with the Ca2+ sensitive dye Rhod dextran and fluorescence monitored 
at 10 second intervals for ~10 hours. The fluorescence of the dye is plotted as a ratio 
relative to the starting fluorescence signal.  Further experimental details are given in 
elsewhere [18,32].   
 
Fig.2. A schematic representation of the known methods of generating Ca2+ 
increases in human oocytes. Electroporation in the presence of Ca2+ causes Ca2+ 
influx into the cytosolic compartment and, as used so far, leads to a single large Ca2+ 
increase. Ca2+ ionophores, A23187 and ionomycin, cause Ca2+ release principally 
from the endoplasmic reticulum (ER) and a single large Ca2+ rise. The sperm 
introduces PLC which generates InsP3 and a series of Ca2+ oscillations. The 
general pattern of Ca2+ transients induced by each stimulus is represented in red.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig ϭ. CaϮ+ oscillatioŶs duriŶg fertilizatioŶ iŶ a ŵouse oocyte  
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Fig Ϯ. Scheŵatic represeŶtatioŶ of ŵechaŶisŵs for geŶeratiŶg 
CaϮ+ iŶcreases iŶ huŵaŶ oocytes.  
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